CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06084481
Title field or adapter rule: {'original_value': 'A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:23.460721+00:00
Published At: 2026-10-14T00:00:00+00:00
Record Updated At: 2026-10-14
Source Retrieved At: 2026-10-31T22:17:52.415050+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

protocolSection.conditionsModule.conditions: ["Hepatocellular Carcinoma", "Pancreatic Ductal Adenocarcinoma", "Biliary Tract Cancers", "Esophageal Squamous Cell Carcinoma", "Triple Negative Breast Cancer", "Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer", "Head and Neck Squamous-Cell Carcinoma", "Platinum Resistant High Grade Epithelial Ovarian Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-14", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT06084481"
protocolSection.identificationModule.officialTitle: "A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct: null

{'armGroupLabels': ['Cohort 10: PROC/Primary Peritoneal/Fallopian Tube Cancer', 'Cohort 1: Hepatocellular Carcinoma (HCC)', 'Cohort 2: Pancreatic Ductal Adenocarcinoma (PDAC)', 'Cohort 3: Biliary Tract Cancers (BTC)', 'Cohort 4: Esophageal Squamous Cell Carcinoma, (ESCC)', 'Cohort 5: Triple Negative Breast Cancer (TNBC)', 'Cohort 6: Hormone Receptor+/HER2-breast Cancer (HR+/HER2-BC)', 'Cohort 7: Head and Neck Squamous-cell-carcinoma (HNSCC)', 'Cohort 8: PROC/Primary Peritoneal/Fallopian Tube Cancer', 'Cohort 9: Drug-Drug Interaction'], 'description': 'Intravenous (IV) Infusion', 'name': 'ABBV-400', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Cohort 9: Drug-Drug Interaction'], 'description': 'Oral Solution', 'name': 'Itraconazole (ITZ)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Cohort 10: PROC/Primary Peritoneal/Fallopian Tube Cancer'], 'description': 'IV Infusion', 'name': 'Bevacizumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.